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Intracellular proteolysis is critical to maintain timely degradation of altered proteins including oxidized
proteins. This review attempts to summarize the most relevant ﬁndings about oxidant protein mod-
iﬁcation, as well as the impact of reactive oxygen species on the proteolytic systems that regulate cell
response to an oxidant environment: the ubiquitin-proteasome system (UPS), autophagy and the un-
folded protein response (UPR). In the presence of an oxidant environment, these systems are critical to
ensure proteostasis and cell survival. An example of altered degradation of oxidized proteins in pathology
is provided for neurodegenerative diseases. Future work will determine if protein oxidation is a valid
target to combat proteinopathies.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
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Aerobic metabolism has the advantage of a better energy yield,
but at the cost of generating reactive oxygen species (ROS). Indeed,
the leakage of superoxide from mitochondrial respiratory chain
complexes I and III constitutes one of the major sources of ROS
production [1]. Other sources of harmful ROS include unfolded
protein response at the endoplasmatic reticulum (ER) [2], and
oxidant byproducts generated at peroxisomes [3,4]. Moreover,
evolution has used oxygen to modify certain proteins, now termed
redox switches, as a cell signaling mechanism in survival [5] and
regeneration [6] among other pathways. This clever use of ROS is
best exempliﬁed by NADPH oxidases (NOX), situated in the plasma
membrane, whose main role is to generate superoxide and ulti-
mately hydrogen peroxide (H2O2) as second messengers [7].
Cells have efﬁcient enzymatic and non-enzymatic strategies to
modulate redox signaling and maintain redox homeostasis [8,9]. In
addition, antioxidants are also obtained from exogenous sources,
with the diet as the main supplier [10]. However, many patholo-
gical conditions or the normal decline in cell homeostasis relatedFig. 1. Oxidation of sulfur containing amino acids. A, Reversible modiﬁcations modulat
containing amino acids methionine (Met) and cysteine (Cys) may undergo oxidation to
and S-nitrosothiols. B, Sulfur-containing amino acids can be further oxidized to irreve
conditions of oxidative stress and lead to structural changes, protein inactivation and u
the protein backbone by hydroxyl radical or direct oxidation or adduct formation of
hydroxylation of aromatic groups and aliphatic amino-acid side chains, nitration of a
residues to carbonyl derivatives and glycoxidation (adduction of advanced aged glycatioto ageing lead to a gradual imbalance between ROS formation and
degradation and result in detrimental alterations of macro-
molecules. Sulfur containing amino acids, cysteine and methio-
nine, are responsible for reversible and irreversible modiﬁcation of
proteins. In addition, proteins can form adducts with oxidizing
byproducts. Fig. 1 summarizes oxidative modiﬁcations of sulfur
containing amino acids.
In this review, we summarize the most relevant ﬁndings about
the degradation of oxidized proteins, here termed oxyproteins,
and the impact of oxidative stress on proteolytic cell systems, and
gene expression.2. The ubiquitin-proteasome system (UPS) in the control of
oxyprotein degradation
The UPS participates in the degradation of soluble proteins in
cytosol and nucleus [11]. The central core of the UPS is the 20S
proteasome, which is present in animals, plants and bacteria. This
700 kDa-multisubunit protease is highly effective in the proteolytice physiological protein functions that act as molecular redox switches. The sulfur-
generate Cys disulﬁdes, S-thiolates, S-sulfenates, Met-sulfoxides, S-glutathionylates
rsible sulfonic acid. Irreversible oxidative modiﬁcations, typically occur under the
ltimately require protein degradation. Irreversible modiﬁcations lead to cleavage of
the side chain amino acids. Oxidative modiﬁcations to amino acids include the
romatic amino-acid residues, oxidized lipid adduction, conversion of amino-acid
n end products) (this ﬁgure has been adapted from [156] and [157]) .
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karyotes, the 20S proteasome binds one or two regulatory 19S
complexes to give rise to the 26S proteasome, changing its activity
and speciﬁcity towards native folded proteins [12,13].
The main difference between ubiquitin (Ub)-dependent and
Ub-independent proteasomal degradation is ATP-requirement.
Based on this, the fact that ATP addition to cell lysate had no effect
or even decreased proteasomal degradation of oxyproteins, led to
the conclusion that these proteins are degraded by the 20S pro-
teasome independently of both regulatory 19S complex and Ub
[14–16]. In accordance to this, the 26S proteasome and the ubi-
quitinating machinery are much more sensitive than its 20S core
to oxidative stress [17,18]. Thus, 20S proteasomal degradation is
unaffected by H2O2 concentrations of up to 5 mM, while ATP-de-
pendent degradation by the 26S proteasome begins to decline at
400 mM, and is completely abolished at 1 mM [19,20].
On the other hand, some oxyproteins might require ubiquitin-
dependent 26S proteasome degradation [21,22]. Thus, Dudek and
co-workers [21] showed that carbonyl-containing proteins, a di-
rect measure of protein oxidation, are selectively removed by
ubiquitinating machinery. Furthermore, it has been reported that
inhibition of USP14, deubiquitinating enzyme that associates with
the proteasome, may enhance the clearance of oxyproteins, and
thus, cellular resistance to oxidative challenges [22]. Based on the
extensive review of Aiken and co-workers [23] and Shang and
Taylor [24] changes in proteasomal activity upon oxidative pres-
sure are illustrated in Fig. 2.Fig. 2. Proposed model of oxidative stress-dependent regulation of the 26S proteasome.
which removes folded and functional proteins by ATP/Ub-dependent mechanism. It has b
in order to protect the cell from oxidatively damaged proteins. However, under persist
tinating system becomes deactivated. In this way 20S proteasome becomes the prefere
higher resistance of 20S proteasome to oxidative injures in comparison to its 26S counte
the ATP/Ub-independent manner. This is accomplished probably by recognition of expos
the natively folded protein, but become exposed as a consequence of oxidative modiﬁ
disassembly of 26S proteasome is reversible, and thus removal of oxidative stress lead
thermore, after several hours of recovery from oxidative stress, hyperactivation of the ubi
continues proteasomal activities are inhibited and de novo synthesis of both standard a
vated, giving rise to newly-formed 20S, i20S and i26S proteasomes, i.e. both ATP/Ub-dep
persist still and/or increases (sublethal level), the proteolytic system becomes impairedApart from its role in the degradation of oxidatively damaged
proteins, the proteasomal system is also involved in highly con-
trolled degradation of proteins acting as redox switches. This is the
case of certain transcription factors such as hypoxia-inducible
factor-1 (HIF-1), Nuclear factor (erythroid-derived 2)-like 2 (NRF2)
or nuclear factor kappa B (NFκB) [25,26] as illustrated in Fig. 3.
The UPS itself is subjected to alterations derived from oxidative
stress. As shown in Fig. 4, ubiquitinating enzymes are inactivated by
disulﬁde bond formation, S-nitrosylation, and S-glutathionylation
[27,28]. The E3 ligase adapter kelch-like ECH-associated protein 1
(KEAP1) is an excellent example (Fig. 3B). The proteolytic activity of
the proteasome requires intact sulfhydryl groups of Cys residues in
the beta subunits of the calatytic 20S core for catalysis. These Cys
are largely responsible for the susceptibility of the proteasome to
oxidative insults. Moreover, both core 20S and regulatory 19S
complexes are targets of oxidative modiﬁcation, including 4-hy-
droxynonenal modiﬁcation, carbonylation, S-glutathionylation, gly-
coxidation, as well as ADP-rybosilation and phosphorylation, which
are indirect ROS-induced modiﬁcations (Fig. 4). Considering that the
26S proteasome is much more sensitive to oxidative stress than its
20S core, it is not surprising that almost all these modiﬁcations were
detected on the 19S regulatory subunits leading to decreased ac-
tivity of the 26S proteasome [29–31]. Although the majority of these
modiﬁcations result in decreased 20S proteasome activity, some of
them show the opposite effect. Thus, it has been shown that
S-glutathionylation of two Cys residues on α5 subunits of 20S in
yeast, increases proteasome activity via opening of the annulus [32].Under basal conditions, 26S proteasome is the major cellular proteolytic machinery,
een suggested that its activity may be enhanced upon the onset of oxidative stress,
ent oxidative stress conditions, the 26S proteasome disassembles, and the ubiqui-
ntial cytosolyc, but also nuclear, proteolytic machinery. In accordance to this is the
rpart. Released 20S proteasome may now degrade oxidatively degraded proteins in
ed hydrophobic structures on the target protein, which are normally buried inside
cation-induced conformational changes of the proteins. Importantly, at this stage
s to reassembly of the 26S proteasome, and recovery from oxidative injures. Fur-
quitinating system, as well as proteolysis, was observed. However, if oxidative stress
nd inducible proteasomal components (including 11S regulatory complex) is acti-
endent and-independent pathways of proteasomal degradation. If oxidative stress
, giving rise to accumulations and aggregates of damaged or abnormal proteins.
M. Pajares et al. / Redox Biology 6 (2015) 409–420412Also, ADP-ribosylation of Glu, Asp, or Lys of nuclear 20S proteasome
by poly[ADP-ribose] polymerase 1 (PARP1), increases its chymo-
trypsin-like activity [33]. The PARP1 is activated in the response tosingle-strand and double-strand breaks of DNA [34]. Besides ADP-
ribosylation, phosphorylation seems to be important post-transla-
tion modiﬁcation that may regulate proteasome activity upon
M. Pajares et al. / Redox Biology 6 (2015) 409–420 413oxidative stress [35,36], but this still needs to be experimentally
conﬁrmed.
Up-regulation of proteasome genes is coupled with enhanced
capacity of the cell to cope with detrimental effects of oxidative
insult [37]. Thus, it has been shown that increased expression of
the UMP1, proteasome assembly protein, improves cell viability
upon exposure to different oxidants, probably via up-regulation of
the proteasome β subunits [38,39]. It is interesting that NFκB and
activator protein-1 (AP1) do not seem to participate in regulation
of most proteasome genes [40] while Nuclear factor (erythroid-
derived 2)-like 1 (NRF1) and NRF2 appear to have a major role
[40,41]. Thus, it seems that regulation of the proteasomal and
NRF2 activity is bidirectional, i.e. in the basal conditions the pro-
teasome down-regulates NRF2 activity by degradation, while upon
oxidative stress, released NRF2 up-regulates proteasomal activity
and protects the cell from the accumulation of oxyproteins. This
effect may explain why pre-treatment of cultured neurons with
low doses of proteasome inhibitors lead to increased, not de-
creased, proteasomal activity [42].3. Autophagy and degradation of oxyproteins
Autophagy refers to any intracellular process that leads to de-
gradation of cytosolic components inside lysosomes [43,44]. There
are three different types of autophagy in mammals: macro-
autophagy, chaperone mediated autophagy (CMA) and micro-
autophagy [44,45]. Macroautophagy (often referred to as autop-
hagy) is a process in which a portion of the cytosol is surrounded
by a growing double membrane (autophagosome) which even-
tually fuses with the lysosome (autophagolysosome), where the
content will be degraded [43]. Cytosolic substrates with a KFERQ-
like motif can be selectively recognized, translocated and degraded
inside the lysosome by CMA [46,47]. Finally, the direct invagina-
tion of the lysosomal membrane can introduce cytosolic portions
into the lysosome in a type of autophagy called microautophagy
[48].
Mild oxidative stress conditions, redox-mediated signaling or
oxidative modiﬁcation of macromolecules up-regulate the autop-
hagy ﬂux, leading to elimination of non-functional and potentially
damaging protein aggregates and affected organelles (Fig. 5A and
B). Several groups have reported redox-modiﬁcation of autophagy
components with a general effect on autophagy induction, al-
though some exceptions can be found (Table 1). Moreover, ap-
propriate GSH levels are essential for basal autophagy. Indeed,
GILT (gamma-interferon inducible lysosomal thiol reductase)-de-
ﬁcient ﬁbroblasts show decreased GSH levels and increased au-
tophagy, associated with the up-regulation of the ERK signaling
pathway and with nuclear translocation of high-mobility group
protein B (HMGB) [49]. Starvation-induced autophagy decreased
levels of intracellular GSH, which correlated with increasedFig. 3. A. Regulation of the hypoxia-inducible transcription factor 1α (HIF-1α). HIF-1 is
constitutively expressed β subunit. The level of HIF-1α is determined by the relative rat
degraded and exhibits a half-life of just about 5 min. HIF-1α is hydroxylated and rapidly
activity of a class of oxygen-, 2-oxoglutarate-, and iron-dependent enzymes known as pr
Hydroxylation of HIF-1α created a recognition site VHL, a E3 ubiquitin ligase adapter re
tination and subsequent proteasomal degradation of HIF-1α. By contrast, under oxygen-l
dimerizes with HIF-1β and activates transcription of genes containing hypoxia respons
increasing oxygen delivery to the tissues and anaerobic ATP-generation by glycolysis. B, N
factor of redox homeostasis that functions in association with ‘small’ Maf proteins. Under
associating protein 1 (Keap1) and has a very short half life of about 20 min. The Ke
proteasomal degradation. However, under oxidative or electrophilic conditions, speciﬁc
and newly synthesized NRF2 is able to accumulate, translocate to the nucleus and induc
containing an enhancer termed Antioxidant Response Element (ARE) such NAD(P)H qu
glutamate-cysteine ligase, glutathione S-transferases, etc. C, The UPS plays also a role in a
and proteasomal degradation of its inhibitor (IκBα) releases NFκB, which now can freely t
cellular response to stimuli such as stress, cytokines, free radicals, ultraviolet irradiationautophagy ﬂux in different carcinoma cell lines [50].
The importance of redoxtasis for CMA was ﬁrst reported with
the discovery of the degradation of IκB by CMA, as this process was
prevented upon treatment with antioxidants [51]. Further studies
conﬁrmed that CMA can be activated under mild oxidative stress
circumstances and that protein oxidation facilitates the degrada-
tion by CMA [52]. Indeed, when known CMA substrates or a pool
of cytosolic proteins where incubated with increasing amounts of
oxidizing agents, their degradation by CMA was accelerated. One
explanation is that oxidative modiﬁcation of these proteins causes
their partial unfolding, not only promoting the exposure of hidden
recognition motifs to the chaperones but also facilitating its
translocation. Another possibility is that oxidation of certain re-
sidues creates a previously inexistent KFERQ-like motif [53]. In-
creased levels of the CMA mediators LAMP-2A, lys-hsc70, Hip and
hsp90 have been reported in this context, suggesting that in-
creased CMA-mediated protein degradation is due to greater
binding and up-take of substrates into lysosomes [52]. In ac-
cordance with this, CMA down-regulation (through silencing the
expression of LAMP-2A) compromised cell viability upon exposure
to oxidant and pro-oxidant factors (H2O2, paraquat or cadmium)
[54]. Moreover, the ectopic expression of LAMP-2A in liver of aged
rodents (aimed to prevent the age-dependent decrease in CMA)
leads to reduced levels of intracellular oxidized and aggregated
proteins, improves the response to stressors and preserves organ
function [55].
Recently, an oxidative stress-induced form of microautophagy
was described, arising from mitochondria-derived vesicles (MDVs)
[56,57]. MDVs transported to the lysosomes are enriched in oxi-
dized proteins [58] and are generated in response to oxidative
stress [57]. Protein degradation mediated by MDVs does not re-
quire activation of the autophagy key actors Atg5, Rab9 or Beclin-1,
but it does require the protein kinase PINK1 and the ubiquitin E3
ligase Parkin [59]. This suggests that similar mechanisms apply as
in mitophagy, but at restricted patches of the mitochondrial sur-
face. MDVs may thus be generated as a ﬁrst order of defense to
handle redox-damaged proteins in order to prevent functional
failure of the organelle.
Apart from an initial and rapid increase in the autophagy ﬂux
mediated by post-translational protein modiﬁcations, a delayed
and extended autophagy response relies on the activation of
speciﬁc transcription factors such as NRF2, NFκB, p53 or FOXO3a
(Fig. 5D) [60]. NRF2, the master regulator of redox homeostasis,
has been recently related to the modulation of autophagy. The
autophagy-related protein p62/SQSTM1 binds to KEAP1 at the
NRF2 binding site, thus promoting NRF2 release from KEAP1 and
enabling NRF2-dependent gene expression. Binding of p62 to
KEAP1 is favored upon phosphorylation of p62 in an mTORC1
dependent manner [61]. One dimer of p62 can bind to both KEAP1
and LC3, resulting in its degradation. Moreover, the p62 gene has
been shown to be a target of NRF2, creating a positive feedbacka heterodimer transcription factor that consists of an O2-sensitive α subunit and a
io of its synthesis versus degradation. Under normoxic conditions HIF-1α is quickly
degraded by the ubiquitin-proteasome pathway. HIF-1α stability is regulated via the
olyl-4-hydroxylases (PDH), which hydroxylate two prolines at locations 402 or 564.
cruits HIF-1α to the VHL-elongin B and C-Cul2 complex. Thus, VHL directs ubiqui-
imiting conditions, HIF-1α is stabilized, and can translocate to the nucleus where it
e elements (HREs). These genes include those that enhance hypoxia tolerance by
uclear factor (erythroid-derived 2)-like 2 (Nrf2) is a master regulator transcription
basal redox conditions, NRF2 is localized in cytoplasm in association with Kelch ECH
ap1-Cul3-Rbx complex directs polyubiquitination of the Nrf2 and its subsequent
Cys residues of Keap1 undergo oxidative modiﬁcation. Bound NRF2 is not degraded
e the expression of target genes. In the nucleus Nrf2 drives the expression of genes
inone oxidoreductase 1, heme oxygenase 1, catalase, CuZn superoxide dismutase,
ctivation of NFκB. According to canonical pathway of NFκB activation, ubiquitination
ranslocate into nucleus. In this way, NFκB can activate transcription of genes vital for
, and bacterial or viral antigens.
Fig. 4. ROS-induced modiﬁcation of the UPS. Red arrows suggest decreased activity of the proteasomal degradation upon induced modiﬁcation, while blue arrows suggest
that modiﬁcation has opposite effects. On the other side, arrows that points ‘phosphorylation’ to the target proteasomal components are black because the effects of these
modiﬁcation is still experimentally unconﬁrmed, in the oxidative stress conditions. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to
the web version of this article.)
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control p62 gene expression [62]. Interestingly, NRF2 may mod-
ulate other autophagy players as it has been reported to reduce
phospho-TAU levels in a mouse model of AD through inducing the
expression of NDP-52 [63]. Regarding CMA, the levels of LAMP2A
mRNA in the livers of rats treated with paraquat were signiﬁcantly
higher than in untreated rats, although degradation of LAMP2A
was only slightly reduced and the distribution between matrix and
membrane was not altered [52]. The exact transcription factors
involved in this up-regulation have not yet been elucidated, but
ROS regulated T-cell receptor-induced LAMP2A expression may
rely on RISP, DUOX1 or NFAT activities [64].
The induction of autophagy by ROS can, in turn, modulate ROS
levels. Thus, autophagy activation with trehalose was accom-
panied by the up-regulation of glutathione levels, supporting the
antioxidant role of autophagy [65]. Another example is the p53-
inducible TIGAR protein, whose ability to inhibit autophagy has
been correlated with the suppression of ROS, with no clear effects
on the mTOR pathway and is p53 independent [66].
Covalent cross-links, disulﬁde bonds, hydrophobic interactions
and heavily oxidized aggregates are less effectively degraded by
the proteasome [67] and are redirected to degradation by the
autophagy system [67,68]. If these irreversible aggregates become
resistant to hydrolases, they accumulate in the form of lipofuscin
[69,70]. Moreover, cross-linking of proteins at the lysosomal
membrane can increase proton permeability and luminal pH [71].
As a consequence of this, lysosomal hydrolases are less effective at
degrading their substrates, which will favor the accumulation of
lipofuscin [69]. Lipofuscin-loaded human ﬁbroblasts exhibit re-
duced autophagy [72].
Oxidative damage to the lysosomal membrane may lead to the
leakage of hydrolases into the cytosol, resulting in further cellular
damage (Fig. 5C) [73–75]. The direct damage of the lysosomal
membrane by speciﬁc oxyproteins, such as ferritin or low density
lipoproteins (LDL) in macrophages, has been reported [76].
Moreover, lysosomes themselves can be a source of ROS. Thus,
inhibition of autophagy with methylamine, chloroquine or3-methyladenine prevented ROS formation [77]. Autophagy de-
gradation of catalase under caspase inhibition conditions has also
been proposed as a mechanism contributing to the accumulation
of ROS [78]. The degradation of iron-containing macromolecules
or organelles (ferritin or mitochondrial electron transport com-
plexes for example) leads to the intra-lysosomal accumulation of
Fe2þ . Besides, H2O2 resulting from different cellular processes can
either enter the lysosome or be generated in its lumen as a result
of degraded mitochondria. Both species may react (Fenton reac-
tion), resulting in the formation of the extremely reactive hydroxyl
radicals [79].4. The unfolded protein response (UPR) in management of
oxyproteins
The UPR is an adaptive response to ER stress [80] meant to
reduce the protein folding load in the ER and increase ER folding
capacity [81]. This is achieved by a general suppression of trans-
lation, retrotranslocation of proteins and their degradation by
ERAD (ER associated protein degradation), degradation of ER-as-
sociated mRNAs, expansion in ER volume and increased synthesis
of ER chaperones (reviewed in [81]). Oxidative stress leads to
protein unfolding or misfolding in the endoplasmic reticulum (ER)
which in turn produce ER stress and activate the UPR [82].
Three membrane-associated proteins have been identiﬁed for
sensing ER stress in eukaryotes: activating transcription factor 6
(ATF6), pancreatic ER eIF2α kinase (PERK, also double-stranded
RNA-activated protein kinase-like ER kinase), and inositol-requir-
ing kinase 1 (IRE1) [83]. The luminal domain of each sensor is
bound to the chaperone 78 kDa glucose-regulated protein (GRP78/
BiP) in the resting state. GRP78/BiP dissociates upon ER stress to
bind unfolded proteins, leading to the activation of the three
sensors [83,84].
Upon release from GRP78/BiP, ATF6 reaches the Golgi appara-
tus, where it is sequentially cleaved and the fragment generated
(ATF6f) is capable to enter the nucleus and induce transcription of
Fig. 5. Contribution of autophagy to either cell survival or cell death. Basal ROS levels contribute to cell signaling and also basal autophagy, necessary to maintain protein
turnover and proteostasis. A, under mild oxidative stress conditions, redox-mediated signaling and/or oxidative modiﬁcation of macromolecules may up-regulate the
autophagy ﬂux in order to eliminate non-functional and potentially damaging cellular structures, including aggregates and affected organelles. In this context, autophagy
would also exert a pro-survival function. B, the contribution of the lysosomal system to either cell survival or cell death depends on a tightly regulated equilibrium of ROS
and autophagy. C, under chronic or massive oxidative stress circumstances, lysosomes could negatively contribute to cell fate as a source of ROS, leakage of proteases into the
cytosol, degradation of essential cellular components and eventually leading to autophagy cell death. D, the bi-phasic autophagy response to stress. In the ﬁrst phase there is
a rapid increase in the autophagy ﬂux that is mediated by post-translational protein modiﬁcations. This response may be followed by a delayed and extended phase that
relies on the activation of speciﬁc transcriptional programs including NRF2, NFκB, p53 or FoxO3.
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or CHOP [84–88]. ATF6 contains two conserved Cys residues that
can form intra- and intermolecular disulﬁde bonds. Upon ER
stress, only the reduced monomer form can reach the Golgi ap-
paratus to be cleaved and act as a transcription factor, andTable 1
Redox-modiﬁcation and effects of autophagy components.
Stimulus/treatment Oxidative modiﬁed target Co
Starvation-induced ROS (H2O2) Atg4 (inhibition) At
Oxidative stress (H2O2, mitocondrial ROS), hy-
poxia-induced mtROS
AMPK (activation) AM
Genotoxic and oxidative stress ATM (activation) Ac
Oxidative stress Trx (oxidation and dissociation
from ASK1)
Ac
1
S-nitrosylation JNK1, IKKβ (inhibition) De
NO JNK (inhibition) Bc
au
Oxidative stress (H2O2), low NO levels PTEN (inhibition) PI
th
High NO levels Akt (inhibition) Re
co
Sulfhydration PARKIN (activation) In
m
O-GlcNAcylation BCL2, BECLIN-1 In
O-GlcNAcylation AMPK (activation) AMtherefore redox control of the disulﬁde bonds in ATF6 is crucial for
its export [89].
Most of the PERK signaling is mediated through phosphoryla-
tion of the alpha subunit of the eukaryotic initiation translation
factor 2 (eIF2α), which transiently inhibits protein translation.nsequences in autophagy Ref.
g4 cannot delipidate LC3, increased autophagy [143]
PK inhibits mTORC1 and activates ULK1, increased autophagy [144–146]
tivation of AMPK and TSC2, increased autophagy [141–147]
tivation of ASK1, which activates JNK1 promoting release of Beclin
and autophagy induction
[148–150]
creased phosphorylation of AMPK and TSC2, decreased autophagy [150,151]
l-2 phosphorylation, decreased Bcl2-Beclin1 complex, increased
tophagy
[150,151]
3K/Akt activation, phosphorylation of Beclin-1 and activation of
e mTOR complex, autophagy inhibition
[150,152]
duced phosphorylation of Beclin-1 and inactivation of the mTOR
mplex, increased autophagy
[150,152,153]
creased localization to the mitochondrial membrane, increased
itophagy
[154]
hibition of autophagy [154]
PK inhibits mTORC1 and activates ULK1, increased autophagy [155]
Fig. 6. Impact of protein folding on oxidative stress and the UPR. A, Oxidative environment in the ER is crucial for correct protein folding. The highly oxidative environment
in the ER (1:1–1:3 GSH/GSSH ratio compared to the 30:1–100:1 in the cytosol) is required for protein folding; ROS are formed as byproducts of normal protein folding and as
a consequence of incorrect disulﬁde bond formation. Protein disulﬁde isomerases (PDIs) catalize disulﬁde bond formation in nascent proteins, a process necessary for correct
protein folding. Two Cys in the active site of PDI accept two electrons from the Cys of the folding polypeptide. PDIs are then oxidized by oxidoreductin 1 (ERO1) proteins that
subsequently transfer electrons to oxygen to produce H2O2. The generated H2O2 is metabolized into H2O by peroxiredoxin IV. Moreover, improperly paired disulﬁde bonds
can be reduced by PDIs in parallel with glutathione oxidation. ROS produced during protein folding and the consumption of GSH upon the reduction of improperly paired
disulﬁde bonds may shift the redox balance in the ER, favoring the accumulation of misfolded/unfolded proteins and activating the UPR. B, The UPR modulates redoxstasis.
One of the three UPR arms activated upon ER stress is PERK signaling. PERK phosphorylates NRF2, promoting its nuclear translocation and induction of the antioxidant
response. PERK signaling also involves phosphorylation of eIF2α and a transient inhibition of protein translation. However, selective translation of the transcription factor
ATF4 is induced under these circumstances. ATF4 promotes an antioxidant response through the expression of target genes such as HO-1. Although a crosstalk between ATF4
and NRF2 has been described, the underlying mechanisms remain unclear. ATF4-induced CHOP expression results in the expression of Ero1α, an enzyme that causes Ca2þ
leakage from the ER, activating CaMKII in the cytosol, which in turn induces NOX2 and causes oxidative stress. Moreover, CHOP has been implicated in the transcriptional
repression of Bcl2 and transactivation of BIM and PUMA that leads to enhanced oxidant injury and apoptosis.
M. Pajares et al. / Redox Biology 6 (2015) 409–420416However, selective translation of the transcription factor ATF4 and
subsequent expression of its target genes is induced under these
circumstances (Fig. 6A) [86]. ATF4 induces expression of genes like
HO-1 and p62/SQSTM1 that are known to be induced upon oxi-
dative stress and can have a role in the modulation of redoxtasis.
Moreover, ATF4-induced CHOP expression results in the expres-
sion of Ero1α, an enzyme that contributes to oxidation in the ER
(Fig. 6A) [90]. Ero1α causes Ca2þ leakage from the ER, activating
CaMKII in the cytosol, which in turn induces NOX2 and causesoxidative stress. Moreover, in cooperation with FoxO3, CHOP has
been implicated in the transcriptional repression of Bcl2 and
transactivation of BIM and PUMA that leads to enhanced oxidant
injury and apoptosis (Fig. 6A) [91,92].
PERK phosphorylates NRF2 promoting its dissociation from
KEAP1, translocation to the nucleus and expression of its target
genes [93,94]. Different UPR genes have been reported to contain
AREs in their promoter regions [95]. Since NRF2 also promotes the
expression of proteasome and autophagy-genes it is not surprising
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proteasomal activity [96].
The transcription factor NRF1, also involved in the antioxidant
response, localizes to the ER membrane and may undergo nuclear
translocation upon deglycosilation or intra-membrane/proteaso-
mal cleavage. NRF1 localization along with its ability to up-reg-
ulate proteasomal subunits after proteasome inhibition makes it
reasonable to consider an NRF1 up-regulatory function of ERAD
during ER stress. Tunicamycin treatment of myc-tagged NRF1
transfected cells resulted in higher levels of the 110 kDa Nrf1
fragment in the nucleus when compared with untreated cells.
However, another group later reported that this isoform does not
have the ability to transactivate ARE-containing genes [96].
Activated IRE1 contains both a kinase and a RNAse domain. Its
activation leads to mRNA splicing of an intron from transcription factor
X box binding protein 1 (XBP-1) to trigger its translation [80]. XBP-1
modulates expression of UPR target genes, including ER chaperons,
glycosylation enzymes or ERAD components [97]. Other RNAs are
targeted through a process called regulated IRE1-dependent decay
(RIDD) that reduces the amount of proteins in the ER. IRE1 kinase
domain leads to the activation of the IRE1-TRAF2-JNK axis. Activation
of NRF2 by MAPK is a controversial issue that appears to be context-
dependent. However, in JNK-activated ER stress, the inhibition of JNK
leads to NRF2 over-activation [96]. These results point to NRF2 as a
potential substrate of the IRE1-TRAF2-JNK pathway.
The ER environment is highly oxidative because the ratio GSH/
GSSH is 1:1–1:3 compared to 30:1–100:1 in the cytosol [83]. This
environment favors the formation of disulﬁde bonds necessary for
correct protein folding in an ezymatic reaction catalized by protein
disulﬁde isomerases (PDIs) (Fig. 6B) [98]. These enzymes also re-
duce improperly formed disulﬁde bonds in a process accompanied
by glutathione consumption. Most PDIs contain at least one
thioredoxin (Trx)-like catalytic domain. PDIs are oxidized by oxi-
doreductin proteins 1 (Ero1α and Ero1β in mammals), which re-
generate themselves by transfering electrons to oxygen to produce
H2O2 [98,99]. Peroxiredoxin IV metabolizes H2O2 into H2O [100].
Disruption of redox balance in the ER can result in incorrect dis-
ulﬁde bond formation during protein folding, redox imbalance and
oxidative stress [101].
ROS production and oxidative stress can be considered an in-
tegral component of the UPR, triggering both transcriptional and
post-translational responses which in turn lead to cell adaptation
and survival or cell death by apoptosis.5. Neurodegenerative diseases as models of oxyprotein
pathology
5.1. Prion diseases
Although the physiological role of mammalian prion protein
(PrPc) is not known, there is some evidence suggesting that it
could play a role as endogenous ROS scavenger, protecting other
structural and signaling proteins, because it has a high number of
sulfhydryl groups in methionine residues [102–104]. In addition,
PrPc could be a redox switch since methionine sulfoxidation is
involved in cell signaling [105].With ageing, there is a progressive
accumulation of oxidized methionine residues in PrPc that con-
tribute to protein misfolding, and participate in the transition from
a monomeric globular form with α-helical content to a self-ag-
gregating form with extended β-strand-rich structure with “in-
fective” capacity to transmit the corrupted conformation to other
native prion proteins [106,107]. The transition of PrPc N-terminal
region, from a random coil to a β-sheet structure transforms the
soluble and protease-sensitive PrPc into the oxidized, insoluble
and relatively protease-resistant PrPsc [108,109]. PrPsc monomersand small oligomers induce nerve cell death after internalization
and accumulation into the endolysosomal compartment where
they cause lysosomal damage with subsequent proteolytic enzyme
leakage and activation of caspase-dependent apoptosis [110,111].
Autophagy efﬁciency is also attenuated, due to PrPsc protease-
resistance, and aggregation of misfolded PrPsc also leads to mi-
tochondrial failure [112–114]. Assuming that the primary role of
PrPc is to act as a global cell antioxidant, regulating the oxidative
state of structural and signaling proteins, the conversion of soluble
PrPc proteins to less soluble and aggregation prone oxidized PrPsc
proteins could lead to a major depletion of the antioxidant PrPc
pool thus leading to neuronal death.
5.2. Alzheimer's Disease (AD)
The key pathological features of Alzheimer’s disease are the
presence of soluble amyloid β-peptides, for example Aβ(1–42), that
accumulate in the intracellular and extracellular space and neu-
roﬁbrillary tangles made of TAU protein aggregates. The amyloid β-
peptides can be further modiﬁed into misfolded Aβ monomers,
dimers, oligomers and intermediate products that are toxic, lead-
ing to cell death [115,116]. The oxidation of Aβ(1–42) at the 35
methionine residue promoted by for example H2O2 or Cu2þ , ac-
celerates the production of toxic Aβ(1–42) products and further
protein oxidation and lipid peroxidation [117]. Compared to re-
duced Aβ(1–42), oxidized Aβ(1–42) is more resistant to degrada-
tion by autophagy and endosome–lysosome fusion which further
contributes to its accumulation and toxic effects due to release of
undigested contents into the cytosol [118–121]. The toxicity of
amyloid β-peptide derivatives decreases with protoﬁbril and ﬁbril
formation and terminates in the formation of stable and inert
amyloid plaques [115,116]. Increased ROS formation, inside or
outside the cell, favors the transition of Aβ monomers into toxic
forms and also stimulates the breakdown of microtubule cytos-
keleton by promoting zinc- or H2O2-induced TAU phosphorylation
[116,122]. Hyperphosphorylated TAU, together with the oxidized
form of Aβ(1–42), leads to mitochondrial damage, subsequent re-
duction in ATP production, decreased mitochondrial potential,
production of more ROS and ﬁnally cell death [123].
Monomeric TAU is a natively unfolded and short-lived protein,
thus being a good substrate for the 20S proteasome under normal
conditions [124]. Under stressing conditions it has been reported
that the E3 ligase CHIP (Carboxy terminus Hsp70 interacting Pro-
tein), participates in TAU ubiquitlation leading to its degradation
by the 26S proteasome [125]. However, as indicated before, the
26S proteasome is sensitive to oxidative stress and loses efﬁcacy in
degradation of TAU, particularly when it has undergone post-
translational modiﬁcations (phosphorylation and oxidation among
other modiﬁcations) and led to formation of toxic oligomers and
aggregation. In fact, it has been reported that the proteasome ac-
tivity is impaired in AD brains [126] and that TAU-containing
paired helical ﬁlaments inhibit the proteasome [127]. Under these
conditions TAU is degraded by p62-driven macroautophagy and
LAMP2A-driven chaperone mediated autophagy [128]. Of note,
chaperone mediated autophagy is up-regulated under oxidative
stress conditions, further suggesting its role in degradation of
oxidized and aggregated TAU [52]. A new mechanism of redox-
dependent degradation of TAU has been described [63]. The gene
coding the autophagy adapter protein NDP52, contains several
antioxidant response elements regulated by NRF2. In fact, in Nrf2-
knockout mice, phosphorylated TAU accumulates in the brains
concurrent with decreased levels of NDP52. In summary, TAU is a
substrate of both the proteasome and the autophagy systems and
both processes appear to be impaired in AD [129].
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α-Synuclein (α-SYN) is localized to presynaptic terminals in the
central nervous system and modulates vesicular release of dopamine
[130–132] by attenuating its release under circumstances of repeated
ﬁring [133]. In vivo, α-SYN can be present as a soluble unfolded protein
that can aggregate into progressively less soluble oligomers, proto-
ﬁbrils and insoluble amyloid ﬁbril form [134]. This protein is normally
degraded through the UPS, macroautophagy or CMA; but nitration
and oxidative modiﬁcations slow down or even inhibit its proteasomal
degradation. Besides, partial degradation can lead to its C-terminal
truncation, favoring further aggregation. In addition, α-syn contains a
KFERQ consensus sequence and oxidation of this protein (for instance,
dopamine-modiﬁed α-syn) prevents its translocation into the lyso-
some lumen, acting as uptake blockers and preventing degradation of
other CMA substrates. Attenuation of chaperone-mediated autophagy
degradation leads to a compensatory increase in macroautophagy,
accumulation of autophagosomes, and ultimately to cell death due to
the release of undigested contents into the cytosol [135]. Posttransla-
tional modiﬁcation of α-SYN, for example by phosphorylation, ubi-
quitination, nitration or oxidation, also reduces autophagosome de-
gradation and promotes α-SYN oligomerisation. The toxic effect of
these posttranslational modiﬁcations can be compounded by the
propensity of α-SYN to bind to various molecules in neuronal cells
[136]. For example, Fe2þ , dopamine or H2O2 oxidize methionine re-
sidues in the α-SYN monomer, that is the predominant form of oxi-
dized α-SYN, and also promote the formation of stable oligomers with
a resistance to ﬁbrilisation that is proportional to the number of oxi-
dized methionine residues [137]. The oxidized α-SYN monomer can
interact with lipids, as well as with proteins, changing their redox state
and function thus sharing similarities with the oxidized Aβ(1–42)
[138]. For example, the oxidized α-SYN monomer disrupts autophagy
and also disrupts mitochondrial function [139–141].
Recently, it has been shown that the Parkinson's associated
protein DJ-1 binds to and inhibits the 20S proteasome and thus
prevents the degradation of substrates such as a-syn or p53.
Moreover, under oxidative stress conditions, DJ-1 induces the
NRF2-dependent antioxidant response. Among the induced genes,
NQO1 reinforces DJ-1 function by also inhibiting the 20S protea-
some. However, NRF2 also induces the expression of 20S protea-
some subunits. This robust regulation may be necessary to main-
tain proper 20S proteasome activity [142].6. Future perspectives
Oxidative modiﬁcation of proteins and proteolytic pathways com-
promise protein quality and cell viability. These events may be among
the most relevant in driving protein toxicity in several pathologies as
exempliﬁed here for neurodegenerative diseases. It is now essential to
ﬁnd ways to prevent these effects through either reinforcing redox
homeostasis or increasing the capacity of proteolytic systems.Acknowledgments
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